AFA
REGN icon

AA Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

AA Financial Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-448
Closed -$284K – 194
2025
Q1 		$284K Hold
448
– – 0.07% 139
2024
Q4 		$319K Buy
448
+62
+16% +$52K 0.09% 129
2024
Q3 		$406K Buy
386
+41
+12% +$45.6K 0.12% 111
2024
Q2 		$363K Buy
345
+43
+14% +$41.7K 0.13% 116
2024
Q1 		$291K Buy
+302
New +$287K 0.12% 127

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AA Financial Advisors's REGN Position: Q2 2025 in Review

AA Financial Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 448 shares — an estimated $284K sold.

AA Financial Advisors first reported a position in REGN in Q1 2024 and held it in 5 quarters. The position peaked at $406K in Q3 2024. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • AA Financial Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • AA Financial Advisors sold 448 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $284K.
  • AA Financial Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • AA Financial Advisors's Regeneron Pharmaceuticals position peaked at $406K in Q3 2024.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on AA Financial Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.